Analyses Risques-avantages Et Qualité de Vie Des Médicaments Prescrits

Analyses Risques-avantages Et Qualité de Vie Des Médicaments Prescrits PDF Author: George W. Torrance
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 132

Get Book Here

Book Description
This document encourages the use of quality-of-life measurement techniques in the clinical trail for certain new drugs. It also endorses utility measurement in particular as a powerful technique for determining the balance of risks versus benefits for many new medicines.

Analyses Risques-avantages Et Qualité de Vie Des Médicaments Prescrits

Analyses Risques-avantages Et Qualité de Vie Des Médicaments Prescrits PDF Author: George W. Torrance
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 132

Get Book Here

Book Description
This document encourages the use of quality-of-life measurement techniques in the clinical trail for certain new drugs. It also endorses utility measurement in particular as a powerful technique for determining the balance of risks versus benefits for many new medicines.

RISK-BENEFIT AND QUALITY-OF-LIFE ANALYSES OF PRESCRIPTION DRUGS.

RISK-BENEFIT AND QUALITY-OF-LIFE ANALYSES OF PRESCRIPTION DRUGS. PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 110

Get Book Here

Book Description


National Library of Medicine Current Catalog

National Library of Medicine Current Catalog PDF Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1332

Get Book Here

Book Description


Current Catalog

Current Catalog PDF Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1628

Get Book Here

Book Description
First multi-year cumulation covers six years: 1965-70.

Canadiana

Canadiana PDF Author:
Publisher:
ISBN:
Category : Canada
Languages : en
Pages : 1346

Get Book Here

Book Description


Microlog, Canadian Research Index

Microlog, Canadian Research Index PDF Author:
Publisher:
ISBN:
Category : Canada
Languages : en
Pages : 1222

Get Book Here

Book Description
An indexing, abstracting and document delivery service that covers current Canadian report literature of reference value from government and institutional sources.

Government of Canada Publications, Quarterly Catalogue

Government of Canada Publications, Quarterly Catalogue PDF Author:
Publisher:
ISBN:
Category : Canada
Languages : fr
Pages : 1566

Get Book Here

Book Description


Disaster risk reduction in school curricula: case studies from thirty countries

Disaster risk reduction in school curricula: case studies from thirty countries PDF Author:
Publisher: UNESCO
ISBN: 9230010871
Category :
Languages : en
Pages : 209

Get Book Here

Book Description


Ethnopharmacologie, sources, méthodes, objectifs

Ethnopharmacologie, sources, méthodes, objectifs PDF Author: Jacques Fleurentin
Publisher: IRD Editions
ISBN: 9782709910385
Category : Ethnobotany
Languages : fr
Pages : 502

Get Book Here

Book Description


Managing Breast Cancer Risk

Managing Breast Cancer Risk PDF Author: Monica Morrow
Publisher: PMPH-USA
ISBN: 9781550092608
Category : Breast
Languages : en
Pages : 328

Get Book Here

Book Description
Managing Breast Cancer Risk is a single source for information needed by primary care physicians, nurses, gynecologists, as well as oncologic specialists who deal with women who are concerned about breast cancer. Its purpose is to bring together a multidisciplinary group of experts to address breast cancer risk in a clinically meaningful way. Chapters providing detailed information on individual risk factors are accompanied by a discussion of models, which integrate multiple factors for a more complete assessment of risk. Traditional strategies for risk management, including surveillance and prophylactic surgery, are reviewed, and the data on newer techniques such as ductal lavage and screening with magnetic resonance is presented. The rational for chemoprevention with selective estrogen receptor modulators (SERMS) is discussed, and the evidence for tamoxifen as a chemopreventative is updated. The potential for chemoprevention with newer SERMS and the aromatase inhibitors is reviewed. Finally, the critical (and often ignored) areas of quality of life and symptom management are addressed.